Inicio › Cáncer de próstata › Maryland › Baltimore
Ensayos clínicos de Cáncer de próstata en Baltimore, MD
42 estudios para Cáncer de próstata buscan participantes en centros de Baltimore y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
ReclutandoEstudio observacional
- Chesapeake Urology Associates, Towson · A 8 mi de distancia
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
ReclutandoFase 1
- University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 2
- Johns Hopkins University, Baltimore
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
ReclutandoFase 3
- Baltimore Veterans Affairs Medical Center ( Site 0069), Baltimore
- Greenebaum Comprehensive Cancer Center ( Site 0049), Baltimore
- Chesapeake Urology ( Site 0009), Towson · A 8 mi de distancia
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
ReclutandoFase 3
- University of Maryland Greenebaum Cancer Center, Baltimore
- Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center, Baltimore
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
ReclutandoFase 3
- Research Site, Towson · A 8 mi de distancia
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
ReclutandoFase 3
- Greenebaum Comprehensive Cancer Center ( Site 0021), Baltimore
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
ReclutandoFase 2
- Chesapeake Urology Research Associates, Towson · A 8 mi de distancia
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
ReclutandoEstudio observacional
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Reclutando
- Anne Arundel Urology, Annapolis · A 22 mi de distancia
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
ReclutandoFase 3
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Veterans Administration Medical Center-Baltimore, Baltimore
- y 4 más
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
Reclutando
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- y 2 más
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
Reclutando
- Johns Hopkins Hospital, Baltimore
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
ReclutandoFase 2
- University of Maryland Greenebaum Cancer Center, Baltimore
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
ReclutandoFase 1/2
- Johns Hopkins Hospital, Baltimore
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
ReclutandoFase 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
ReclutandoFase 1
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
ReclutandoEstudio observacional
- Johns Hopkins University, Baltimore
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
ReclutandoFase 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
ReclutandoFase 2
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
ReclutandoFase 1
- Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore
7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer
Reclutando
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
The COSMYC Trial (COmbined Suppression of MYC)
ReclutandoFase 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
ReclutandoFase 1
- Advanced Molecular Imaging and Therapy, Glen Burnie · A 9 mi de distancia
- United Theranostics - Chesapeake, Glen Burnie · A 9 mi de distancia
TERPS Trial for de Novo Oligometastic Prostate Cancer
ReclutandoFase 2
- Maryland Proton Treatment Center, Baltimore
- UMMC, Baltimore
- Baltimore Washington Medical Center, Glen Burnie · A 9 mi de distancia
- y 1 más
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
ReclutandoEstudio observacional
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Clinical Trial of Approaches to Prostate Cancer Surgery
Reclutando
- Johns Hopkins University, Baltimore
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
ReclutandoFase 2/3
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
ReclutandoEstudio observacional
- Johns Hopkins University, Baltimore
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
ReclutandoFase 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
ReclutandoFase 2
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
ReclutandoFase 1 temprana
- SKCCC at Johns Hopkins, Baltimore
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ReclutandoFase 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
ReclutandoFase 1
- Chesapeake Urology, Towson · A 8 mi de distancia
Physician- and Patient-based Barriers to NGS Testing
Reclutando
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
ReclutandoFase 2
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe
ReclutandoFase 1
- Johns Hopkins Hospital, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · A 8 mi de distancia
Exercise in Prostate Cancer
Reclutando
- Johns Hopkins University, Baltimore
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
ReclutandoFase 1/2
- Johns Hopkins, Baltimore
Más información sobre Cáncer de próstata en MedlinePlus
Ensayos de Cáncer de próstata en otras ciudades
- New York City, NY103 estudios
- Houston, TX76 estudios
- Los Angeles, CA61 estudios
- Boston, MA60 estudios
- St. Louis, MO47 estudios
- San Francisco, CA45 estudios
- Chicago, IL45 estudios
- Seattle, WA44 estudios
- Philadelphia, PA44 estudios
- Nashville, TN43 estudios
- Washington, DC38 estudios
- Dallas, TX36 estudios
Otros estudios en Baltimore
- Cáncer de pulmón de células no pequeñas60 estudios
- Cáncer de seno47 estudios
- Cáncer de pulmón40 estudios
- Cáncer (todos los tipos)38 estudios
- Cáncer de páncreas32 estudios
- Cáncer del colon y del recto31 estudios
- Cáncer metastásico28 estudios
- Obesidad25 estudios
- Cáncer de vejiga24 estudios
- Fallo cardíaco24 estudios
- Accidente cerebrovascular22 estudios
- Cáncer de ovario21 estudios
De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.